HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
BLNK
B cell linker
Chromosome 10 Β· 10q24.1
NCBI Gene: 29760Ensembl: ENSG00000095585.18HGNC: HGNC:14211UniProt: Q2MD54
74PubMed Papers
21Diseases
0Drugs
15Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
intracellular signal transductionenzyme bindingB cell receptor signaling pathwaycytosolisolated agammaglobulinemiaagammaglobulinemiaautosomal agammaglobulinemiaalcohol drinking
✦AI Summary

BLNK (B cell linker) is a central adaptor protein that orchestrates B cell receptor (BCR) signaling by bridging the SYK kinase to multiple downstream pathways 1. BLNK is essential for BCR-mediated phospholipase C-gamma (PLC-gamma) activation and calcium mobilization 2, and plays critical roles in activating ERK/MAPK, p38, JNK, NF-ΞΊB, and NFAT signaling cascades. It is required for the pro-B to pre-B cell transition and may contribute to BCR-induced B cell apoptosis 1. Beyond B cell function, BLNK unexpectedly regulates innate antifungal immunity by negatively modulating macrophage migration through C-type lectin receptor signaling; BLNK-deficient mice show enhanced resistance to Candida albicans infection 3. Clinically, BLNK deficiency causes autosomal recessive agammaglobulinemia with impaired B cell development 4. BLNK alterations are implicated in Philadelphia chr10-like acute lymphoblastic leukemia, where BLNK activating mutations contribute to aberrant kinase signaling 5. Recent Mendelian randomization studies identified genetically predicted BLNK levels as a causal risk factor for Alzheimer's disease in European ancestry populations 6, and BLNK has been associated with microglial dysfunction in AD pathology 7. Additionally, BLNK expression is dysregulated in chr10 prostatitis, where it modulates inflammatory responses 8.

Sources cited
1
BLNK functions as a central adaptor bridging SYK kinase to signaling complexes and is required for BCR signaling
PMID: 11680012
2
BLNK is essential for PLC-gamma2 phosphorylation and calcium influx in pre-BCR signaling
PMID: 15270728
3
BLNK negatively regulates macrophage migration and innate antifungal immunity, with BLNK-deficient mice showing enhanced resistance to Candida albicans
PMID: 39413134
4
BLNK is a key B cell signaling component and its deficiency is associated with B cell development impairment
PMID: 14978070
5
BLNK alterations activate kinase signaling in Philadelphia chromosome-like acute lymphoblastic leukemia
PMID: 28972016
6
Genetically predicted BLNK levels show causal association with increased Alzheimer's disease risk in European ancestry populations
PMID: 40050982
7
BLNK is linked to microglial phagocytosis dysregulation in Alzheimer's disease pathology
PMID: 41315858
8
BLNK expression is upregulated in chronic prostatitis and modulates inflammatory responses through calcium signaling
PMID: 41003929
Disease Associationsβ“˜21
isolated agammaglobulinemiaOpen Targets
0.68Moderate
agammaglobulinemiaOpen Targets
0.47Moderate
autosomal agammaglobulinemiaOpen Targets
0.37Weak
alcohol drinkingOpen Targets
0.32Weak
neuroendocrine neoplasmOpen Targets
0.29Weak
agingOpen Targets
0.25Weak
attention deficit hyperactivity disorderOpen Targets
0.23Weak
substance abuseOpen Targets
0.23Weak
Abnormality of the gastrointestinal tractOpen Targets
0.21Weak
genetic disorderOpen Targets
0.19Weak
acute lymphoblastic leukemiaOpen Targets
0.10Weak
classic Hodgkin lymphomaOpen Targets
0.09Suggestive
Hodgkins lymphomaOpen Targets
0.09Suggestive
combined immunodeficiency with skin granulomasOpen Targets
0.09Suggestive
BENTA diseaseOpen Targets
0.09Suggestive
common variable immunodeficiencyOpen Targets
0.08Suggestive
combined immunodeficiency due to CTPS1 deficiencyOpen Targets
0.08Suggestive
immunodeficiency 105Open Targets
0.08Suggestive
immunodeficiency 18Open Targets
0.08Suggestive
agammaglobulinemia 8, autosomal dominantOpen Targets
0.08Suggestive
Agammaglobulinemia 4, autosomal recessiveUniProt
Pathogenic Variants15
NM_013314.4(BLNK):c.902+2T>CLikely pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜…β˜†β˜†2025
NM_013314.4(BLNK):c.289G>T (p.Glu97Ter)Likely pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2025β†’ Residue 97
NC_000010.11:g.96201059delPathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2025
NM_013314.4(BLNK):c.252C>A (p.Tyr84Ter)Pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2024β†’ Residue 84
NM_013314.4(BLNK):c.145C>T (p.Arg49Ter)Likely pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2024β†’ Residue 49
NM_013314.4(BLNK):c.264del (p.Glu89fs)Likely pathogenic
BLNK-related disorder
β˜…β˜†β˜†β˜†2023β†’ Residue 89
NM_013314.4(BLNK):c.747-2A>GLikely pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2023
NM_013314.4(BLNK):c.1195C>T (p.Arg399Ter)Pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2023β†’ Residue 399
NM_013314.4(BLNK):c.26del (p.Val9fs)Pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2022β†’ Residue 9
NM_013314.4(BLNK):c.113+2T>GLikely pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2021
NM_013314.4(BLNK):c.1031del (p.Lys344fs)Pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2020β†’ Residue 344
NC_000010.11:g.96242785delPathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2017
NM_013314.4(BLNK):c.746+1G>ALikely pathogenic
Agammaglobulinemia 4, autosomal recessive
β˜…β˜†β˜†β˜†2017
NM_013314.4(BLNK):c.426G>A (p.Trp142Ter)Likely pathogenic
BLNK-related disorder
β˜†β˜†β˜†β˜†2024β†’ Residue 142
NM_013314.4(BLNK):c.47+3A>TPathogenic
Agammaglobulinemia 4, autosomal recessive
β˜†β˜†β˜†β˜†1999
View on ClinVar β†—
Related Genes
GRAP2Protein interaction100%PLCG1Protein interaction100%IGLL1Protein interaction100%SH3KBP1Protein interaction99%FYNProtein interaction99%BTKProtein interaction99%
Tissue Expression6 tissues
Liver
100%
Bone Marrow
24%
Lung
6%
Heart
3%
Brain
3%
Ovary
1%
Gene Interaction Network
Click a node to explore
BLNKGRAP2PLCG1IGLL1SH3KBP1FYNBTK
PROTEIN STRUCTURE
Preparing viewer…
PDB6YLU Β· 1.88 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.52Moderately Constrained
pLIβ“˜
0.90Intolerant
Observed/Expected LoF0.37 [0.27–0.52]
RankingsWhere BLNK stands among ~20K protein-coding genes
  • #6,383of 20,598
    Most Researched74
  • #2,455of 5,498
    Most Pathogenic Variants15
  • #3,182of 17,882
    Most Constrained (LOEUF)0.52 Β· top quartile
Genes detectedBLNK
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Of mice and not men: differences between mouse and human immunology.
PMID: 14978070
J Immunol Β· 2004
1.00
2
Philadelphia chromosome-like acute lymphoblastic leukemia.
PMID: 28972016
Blood Β· 2017
0.90
3
Microglial phagocytosis in Alzheimer disease.
PMID: 41315858
Nat Rev Neurol Β· 2026
0.80
4
Expression and regulation network of BLNK in CP/CPPS in animal, cell model and clinical samples.
PMID: 41003929
Inflammation Β· 2025
0.70
5
BLNK negatively regulates innate antifungal immunity through inhibiting c-Cbl-mediated macrophage migration.
PMID: 39413134
Proc Natl Acad Sci U S A Β· 2024
0.60